Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study

Objectives: Currently, diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) have proven to be risk factors for each other. This study aimed to determine the risk relationship between COPD and five common oral medications for DM among patients with DM. Methods: This population-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Sheng-Wen, Ho, Yung-Chyuan, Luo, Ci-Wen, Chen, Hung-Yi, Su, Chun-Hung, Kuan, Yu-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797545/
https://www.ncbi.nlm.nih.gov/pubmed/33437213
http://dx.doi.org/10.7150/ijms.55361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797545/
https://www.ncbi.nlm.nih.gov/pubmed/33437213
http://dx.doi.org/10.7150/ijms.55361

Ejemplares similares